Navigation Links
Women & Infants studying therapies to relieve urinary urge incontinence
Date:2/29/2012

Overactive bladder, or the sudden urge to urinate, affects the quality of life of many women. Studies have shown that not all women respond to or can tolerate oral medications and may benefit from other therapies.

Women & Infants Hospital of Rhode Island is conducting a study to compare the effect of two therapies in women who have bothersome urinary urge incontinence after trying other treatments. Patients are currently being enrolled in the ROSETTA Study Reftractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment. The ROSETTA Study is part of the national Pelvic Floor Disorders Network which is funded by the National Institute of Child Health and Development and the Office of Research on Women's Health.

Principal investigator at Women & Infants is Deborah Myers, MD, director of the Division of Urogynecology and Reconstructive Pelvic Surgery at Women & Infants and at The Warren Alpert Medical School of Brown University.

"There are more than 10 million women who suffer from incontinence in America today and more than 50,000 women in Rhode Island alone. That's about one in four between the ages of 30 and 59," said Dr. Myers. "For some women, medications and physical therapy may not help. If we can find another therapy option for these women, we can dramatically impact their quality of life. That's what studies like ROSETTA are all about."

The ROSETTA Study will compare the effect of two therapies in women who have bothersome urinary urge incontinence after trying other treatments. The two new treatments are:

  • Botox, a medication injected into the bladder, or
  • InterStim Therapy, a reversible treatment that uses mild electrical pulses to stimulate nerves going to the bladder (neuromodulation) that influence bladder function.

Women who may be eligible to participate are over 21 years of age, report symptoms of urge incontinence or overactive bladder, experience this leakage two or more times a day, and have tried other treatments including oral medication. Participation will include receiving one of the two procedures and monthly office visits or telephone follow-up for six months and follow-up every three to six months for 24 months.


'/>"/>

Contact: Amy Blustein
ablustein@wihri.org
401-681-2822
Women & Infants Hospital
Source:Eurekalert

Related medicine news :

1. Women decrease condom use during freshman year of college, study finds
2. Fewer women need repeat breast cancer surgeries with new service at University of Michigan
3. The North American Menopause Society (NAMS) reassures many women
4. First study on long-term cognitive effects of breast cancer chemotherapy finds subtle impairment among women who received CMF regimen
5. Stem Cell Finding Could Expand Womens Lifetime Supply of Eggs
6. Contraceptives Work Well in Obese Women, But Hormone Levels Lower
7. Citrus Fruits May Lower Womens Stroke Risk
8. Mammograms Can Save Lives of Women in Their 40s: Study
9. Eating Fish May Help Ward Off Colon Polyps in Women
10. Women with rheumatoid arthritis and lupus give birth to fewer children
11. Circulatory Disorder Not Studied Enough in Women, Experts Say
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... February 28, 2017 , ... ... from 4:30-5:30 p.m. at the 11th Annual RISE Nashville Summit. RISE Nashville is ... performance analytics, and engagement strategies. , The discussion will include best practices for ...
(Date:2/27/2017)... Sedona, Arizona (PRWEB) , ... February 27, 2017 ... ... Premier Center for Shamanic Healing and Spiritual Awakening, is happy to announce ... reboot for mind and body, these individual customized retreats offer the winter-weary soul ...
(Date:2/27/2017)... ... February 27, 2017 , ... This webinar ... analysis as a tool to characterize particle size distributions in the field of ... results and novel scientific findings. It describes methods of optimized and standardized sample ...
(Date:2/27/2017)... CA (PRWEB) , ... February 27, 2017 , ... ... for hair transplantation therapy, is proud to announce a new informational post on ... therapy procedures. Follicular Unit Extraction (FUE) hair transplant and Follicular Unit Transplantation (FUT) ...
(Date:2/26/2017)... ... 2017 , ... This is an extension of airmid’s scope ... ISO/IEC 17025:2005 INAB accredited for Der p 1 (house dust mite allergen) & ... standard that sets out requirements for the technical competence of testing and calibration ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... Prepacked Chromatography columns are widely ... and beverage industry, water and environmental industry, ... laboratories. Acceptance of prepacked chromatography columns is ... pharma companies are increasing, which is anticipated ... Increasing research and development (R&D) activities has ...
(Date:2/28/2017)... SOUTH SAN FRANCISCO, Calif. , Feb. 27, ... company developing proprietary therapeutics for the treatment of ... drug delivery platform, today announced that the U.S. ... initial review of the ropinirole implant Investigational New ... hold the initiation of the clinical study pending ...
(Date:2/28/2017)... Feb. 27, 2017  Market Research presents an all-encompassing and ... optics market titled ,Medical Fiber Optics Market: Global Industry Analysis ... trends globally across the five key regions of ... Europe , APAC and MEA which influence ... fiber optics market over the forecast period. In this report, ...
Breaking Medicine Technology: